Watchmaker Genomics
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $40M
Investors
- 2
About Watchmaker Genomics
Founded in 2019 by Co-Founder and CEO Trey Foskett, and based in Colorado, US, Watchmaker Genomics, Inc. operates as a biotechnology company that engages in applying enzyme technology to do research like reading, writing, and editing DNA. In June 2022, Watchmaker Genomics, Inc.25 million post-money. Watchmaker combines protein engineering with large-scale enzyme manufacturing to address the requirements of high-growth clinical genomics applications. The company's product portfolio includes enzymes and kits for next-generation sequencing library preparation, synthetic biology, and molecular diagnostics. It also offers Watchmaker RNA Library Prep Kit, Watchmaker RNA Library Prep Kits with Polaris Depletion, Equinox Library Amplification Kits, and StellarScript™ Reverse Transcriptase (RT). It also plans to handle an increase in sales, work, or output in a cost-effective, reasonable manner to meet the demand in its industry.
Who invested in Watchmaker Genomics
2 investors across 1 round
See all investors in Watchmaker Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 2, 2022
Amount
$40M
Investors
Questions about Watchmaker Genomics
Who invested in Watchmaker Genomics?
Watchmaker Genomics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Watchmaker Genomics raised?
Watchmaker Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Watchmaker Genomics last raise money?
Watchmaker Genomics's most recent round on record is a Series A, in Jun 2022.
What does Watchmaker Genomics do?
Founded in 2019 by Co-Founder and CEO Trey Foskett, and based in Colorado, US, Watchmaker Genomics, Inc.
Where is Watchmaker Genomics headquartered?
Watchmaker Genomics is headquartered in Boulder, US.
Which VCs invest in companies like Watchmaker Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Watchmaker Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Watchmaker Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.